Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04949360
Other study ID # SleepUp_#01
Secondary ID 34113520.1.0000.
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 5, 2022
Est. completion date December 1, 2025

Study information

Verified date February 2024
Source SleepUp Tecnologia em Saúde Ltda
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cognitive-Behavioral Therapy for insomnia (CBTi) is a well-established therapeutic intervention for insomnia. SleepUp provides a digital therapeutics platform based on CBTi and additional features. This clinical trial aims at analyzing the efficacy of the CBTi-based platform offered by SleepUp in reducing symptoms of insomnia. The sample will be composed of 160 individuals, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild. Those who accept to participate will be randomized and distributed in four groups: - Standard CBTi (CBTi-S): This treatment consists of an eight-week treatment composed by weekly and structure appointments with board-certified sleep psychologists. The appointments will be made remotely (video calls with psychologists). - Minimal intervention - Sleep hygiene (MI-SH): This group informative material regarding normal sleep pattern and sleep hygiene (through regular mail and e-mail). This procedure is more adequate as a control than the commonly used no treatment or waiting list controls, due to the behavioral nature of insomnia. - Online CBTI (CBTI-O): This group will receive access to an eight-month CBTi-based treatment through the SleepUp app. The platform will be updated into a non-commercial version, and all features other than the CBTi track, the sleep log and the clinical tests will be removed. This way, the participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform. The treatment last eight weeks. - Online CBTi + additional features (CBTi-O+): This group will have access to the complete premium version of SleepUp platform. It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth. All participants in all groups will be assessed periodically throughout the eight weeks of intervention with standard sleep questionnaires and sleep logs. Additionally, follow ups will be made at two, four and six months after the end of the intervention. Equivalent intervals will be applied to the SH-MI group.


Description:

Cognitive-Behavioral Therapy for insomnia (CBTi) is a well-established therapeutic intervention for insomnia. In its standard presentation, it is composed by 6 to 12 weekly appointments with a board-certified sleep psychologist. SleepUp provides a digital therapeutics platform based on CBTi and additional features. This clinical trial aims at analyzing the efficacy of the CBTi-based platform offered by SleepUp in reducing symptoms of insomnia. The participants will be recruited based on SleepUp's records and database and invited to participate. Those participants who are eligible in accordance to the inclusion and exclusion criteria will be contact by a member of the research team who will provide a consent form and will explain the terms and conditions of this research project. The sample will be composed of 160 individuals, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild, according to the Insomnia Severity Index (ISI). All groups shall have similar proportions of gender and of insomnia symptoms severity. Those who accepted to participate will be randomized and distributed in four groups: - Standard CBTi (CBTi-S): This is a positive control group, in which standard CBTi (the golden standard behavioral treatment for insomnia) will be made available. This treatment consists of an eight-week treatment composed by weekly and structure appointments with psychologists. Only psychologists board-certified in sleep medicine will perform the CBTi sessions, and none of them are part of the research team. Due to the restriction imposed by the COVID-19 pandemic, the appointments will be made remotely (video calls with psychologists), which have already been proven to be equivalent to the in-person CBTi. - Minimal intervention - Sleep hygiene (MI-SH): This group corresponds to a negative control group, subjected to minimal intervention. It is based on the delivery of informative material regarding normal sleep pattern and sleep hygiene (through regular mail and e-mail). This procedure is more adequate as a control than the commonly used no treatment or waiting list controls, due to the behavioral nature of insomnia. - Online CBTI (CBTI-O): This group will receive access to an eight-month CBTi-based treatment through the SleepUp app. The platform will be updated into a non-commercial version, and all features other than the CBTi track, the sleep log and the clinical tests will be removed. This way, the participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform. The treatment last eight weeks. - Online CBTi + additional features (CBTi-O+): This group will have access to the complete premium version of SleepUp platform. It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth. All participants in all groups will be assessed periodically throughout the eight weeks of intervention. Additionally, follow ups will be made at two, four and six months after the end of the intervention. Equivalent intervals will be applied to the SH-MI group. The following clinical questionnaires and scales will be used: - Sleep log: It includes self-reported items regarding wake and bedtime, sleep latency and other sleeping habits. It allows the calculation of total sleep time, sleep efficiency and wake time after sleep onset. Fille daily. - Morningness and Eveningness Questionnaire: It evaluates chronotype based on 19 items, allowing categorizing the participants according to the following categories: morning type (definitive or moderate), intermediate, or evening type (definitive or moderate). Applied once, in the first week of follow up. - Insomnia Severity Index: It evaluates the presence and severity of insomnia, categorizing the participants according to the following categories: no, mild, moderate or severe insomnia. Applied once every two weeks. - Epworth Sleepiness Scale: It evaluates excessive daytime sleepiness by inquiring about the chance of sleeping in eight daily situations. Scores higher than 10 indicates excessive daytime sleepiness. Applied once every two weeks. - Pittsburgh Sleep Quality Index: It evaluates overall sleep quality based on 19 self-reported items. Scores higher than 5 indicates poor sleep quality. Applied once every two weeks. - Sleep Hygiene Index: It habits related to sleep hygiene, based on 13 self-reported items.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 160
Est. completion date December 1, 2025
Est. primary completion date May 1, 2024
Accepts healthy volunteers No
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - Literate Brazilian portuguese speakers. - Insomnia symptoms (as measured by ISI). - An Android-based smartphone or tablet with access to the Internet. Exclusion Criteria: - Previous experience with CBTi. - Use of sleeping pills or any other treatment for insomnia for two or more days a week in the last three months. - Presence of self-reported co-morbidities (hypertension, hyper/hypothyroidism, asthma, bronquitis or other respiratory diseases, rhinitis, epilepsy and other neurological diseases, any psychiatric disease other than depression and anxiety, diabetes) or sleep disoders other than insomnia.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Online Cognitive-Behavioral Therapy for Insomnia and complementary therapies
The CBTi-O and CBTi-O+ interventions are based on real life user experience. The users will have access to different versions of the platform. The intervention will last eitght weeks.
Regular Cognitive Behavioural Therapy for Insomnia
This is the gold standard behavioral treatment for insomnia and will be performed by independent board-certified sleep psychologists. The treatments will last eight weeks and the appointments will be made by video-calls.
Sleep hygiene - minimal intervention
It is composed by educational material about normal sleep pattern and sleep hygiene. It will be delivered by regular mail and email.

Locations

Country Name City State
Brazil SleepUp Tecnologia em Saúde LTDA São Caetano Do Sul São Paulo

Sponsors (1)

Lead Sponsor Collaborator
SleepUp Tecnologia em Saúde Ltda

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence to the treatment It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it. Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times. These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (SL-MI). On the completion of the intervention (average: 8 weeks)
Primary Response to treatment Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation. On the baseline and on the completion of the intervention (average: 8 weeks)
Primary Remission of symptoms Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8. On the completion of the intervention (average: 8 weeks)
Primary Maintenance of results Among those patients who completed the treatment program, maintenance of results will be calculated based on the same metrics of "response to treatment" and "remission of symptoms". 6 months after the end of the treatment.
Secondary Adherence to the treatment It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it. Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times. These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (SL-MI). 2 weeks after the beginning of the intervention.
Secondary Adherence to the treatment It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it. Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times. These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (SL-MI). 4 weeks after the beginning of the intervention.
Secondary Adherence to the treatment It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it. Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times. These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (SL-MI). 6 weeks after the beginning of the intervention.
Secondary Response to treatment Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation. On the baseline and 2 weeks after the beginning of the intervention.
Secondary Response to treatment Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation. On the baseline and 4 weeks after the beginning of the intervention.
Secondary Response to treatment Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation. On the baseline and 6 weeks after the beginning of the intervention.
Secondary Remission of symptoms Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8. 2 weeks after the beginning of the intervention.
Secondary Remission of symptoms Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8. 4 weeks after the beginning of the intervention.
Secondary Remission of symptoms Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8. 6 weeks after the beginning of the intervention.
Secondary Maintenance of results Among those patients who completed the treatment program, maintenance of results will be calculated based on the same metrics of "response to treatment" and "remission of symptoms". 2 months after the end of the treatment.
Secondary Maintenance of results Among those patients who completed the treatment program, maintenance of results will be calculated based on the same metrics of "response to treatment" and "remission of symptoms". 4 months after the end of the treatment.
Secondary Sleep quality Sleep quality will be measured by the Pittsburgh Sleep Quality Index 2 weeks after the beginning of the treatment
Secondary Sleep quality Sleep quality will be measured by the Pittsburgh Sleep Quality Index 4 weeks after the beginning of the treatment
Secondary Sleep quality Sleep quality will be measured by the Pittsburgh Sleep Quality Index 6 weeks after the beginning of the treatment
Secondary Sleep quality Sleep quality will be measured by the Pittsburgh Sleep Quality Index On the completion of the treatment
Secondary Sleep quality Sleep quality will be measured by the Pittsburgh Sleep Quality Index 2 months after the end of the treatment
Secondary Sleep quality Sleep quality will be measured by the Pittsburgh Sleep Quality Index 4 months after the end of the treatment
Secondary Sleep quality Sleep quality will be measured by the Pittsburgh Sleep Quality Index 6 months after the end of the treatment
Secondary Sleep hygiene Sleep hygiene habits will be measured by the Sleep Hygiene Index 2 weeks after the beginning of the treatment
Secondary Sleep hygiene Sleep hygiene habits will be measured by the Sleep Hygiene Index 4 weeks after the beginning of the treatment
Secondary Sleep hygiene Sleep hygiene habits will be measured by the Sleep Hygiene Index 6 weeks after the beginning of the treatment
Secondary Sleep hygiene Sleep hygiene habits will be measured by the Sleep Hygiene Index On the completion of the treatment
Secondary Sleep hygiene Sleep hygiene habits will be measured by the Sleep Hygiene Index 2 months after the end of the treatment
Secondary Sleep hygiene Sleep hygiene habits will be measured by the Sleep Hygiene Index 4 months after the end of the treatment
Secondary Sleep hygiene Sleep hygiene habits will be measured by the Sleep Hygiene Index 6 months after the end of the treatment
Secondary Excessive daytime sleepiness Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale 2 weeks after the beginning of the treatment
Secondary Excessive daytime sleepiness Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale 4 weeks after the beginning of the treatment
Secondary Excessive daytime sleepiness Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale 6 weeks after the beginning of the treatment
Secondary Excessive daytime sleepiness Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale On the completion of the treatment
Secondary Excessive daytime sleepiness Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale 2 months after the end of the treatment
Secondary Excessive daytime sleepiness Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale 4 months after the end of the treatment
Secondary Excessive daytime sleepiness Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale 6 months after the end of the treatment
See also
  Status Clinical Trial Phase
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT05963542 - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia N/A
Completed NCT06339853 - Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia N/A
Recruiting NCT04069247 - Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia N/A
Completed NCT04493593 - Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility N/A
Recruiting NCT06278077 - Neurexan - a Clinical Trial in Short-Term Insomnia Patients Phase 2
Recruiting NCT05956886 - Sleep Chatbot Intervention for Emerging Black/African American Adults N/A
Completed NCT04661306 - The Better Sleep for Supporters With Insomnia Study N/A
Recruiting NCT06207279 - Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
Recruiting NCT06006299 - Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC) N/A
Completed NCT03683381 - App-based Intervention for Treating Insomnia Among Patients With Epilepsy N/A
Completed NCT04564807 - Testing an Online Insomnia Intervention N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT04035200 - Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation Phase 2
Active, not recruiting NCT05027438 - Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention N/A
Recruiting NCT06053840 - An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia Phase 4
Not yet recruiting NCT06348082 - Project Women's Insomnia Sleep Health Equity Study (WISHES) N/A
Not yet recruiting NCT06363799 - Osteopathic Protocol for Insomnia in College Students N/A
Not yet recruiting NCT05991492 - Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application N/A
Not yet recruiting NCT06025968 - Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis N/A